SI9300223A - Immunogenic peptides/carbohydrate conjugates and process for their production - Google Patents
Immunogenic peptides/carbohydrate conjugates and process for their production Download PDFInfo
- Publication number
- SI9300223A SI9300223A SI9300223A SI9300223A SI9300223A SI 9300223 A SI9300223 A SI 9300223A SI 9300223 A SI9300223 A SI 9300223A SI 9300223 A SI9300223 A SI 9300223A SI 9300223 A SI9300223 A SI 9300223A
- Authority
- SI
- Slovenia
- Prior art keywords
- peptide
- carbohydrate
- cells
- conjugate
- component
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/18—Acyclic radicals, substituted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
- C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/605—MHC molecules or ligands thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/62—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier
- A61K2039/627—Medicinal preparations containing antigens or antibodies characterised by the link between antigen and carrier characterised by the linker
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/16011—Orthomyxoviridae
- C12N2760/16111—Influenzavirus A, i.e. influenza A virus
- C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Mycology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE9201338A SE9201338D0 (sv) | 1992-04-28 | 1992-04-28 | New active compounds |
SE9202553A SE9202553D0 (sv) | 1992-09-07 | 1992-09-07 | New active compounds ii |
SE9203897A SE9203897D0 (sv) | 1992-12-23 | 1992-12-23 | New active compounds iii |
SE9301141A SE9301141D0 (sv) | 1993-04-06 | 1993-04-06 | New active compounds iv |
Publications (1)
Publication Number | Publication Date |
---|---|
SI9300223A true SI9300223A (en) | 1994-03-31 |
Family
ID=27484749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI9300223A SI9300223A (en) | 1992-04-28 | 1993-04-28 | Immunogenic peptides/carbohydrate conjugates and process for their production |
Country Status (19)
Country | Link |
---|---|
US (2) | US5807559A (zh) |
EP (1) | EP0675733B1 (zh) |
JP (1) | JPH07506358A (zh) |
CN (1) | CN1096032A (zh) |
AT (1) | ATE197903T1 (zh) |
AU (1) | AU676679B2 (zh) |
CA (1) | CA2134097A1 (zh) |
DE (1) | DE69329735T2 (zh) |
DK (1) | DK0675733T3 (zh) |
ES (1) | ES2155070T3 (zh) |
GR (1) | GR3035501T3 (zh) |
IL (1) | IL105503A (zh) |
IS (1) | IS4010A (zh) |
MA (1) | MA22885A1 (zh) |
MY (1) | MY108864A (zh) |
PT (1) | PT675733E (zh) |
SI (1) | SI9300223A (zh) |
TN (1) | TNSN93045A1 (zh) |
WO (1) | WO1993021948A1 (zh) |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6083929A (en) * | 1991-05-06 | 2000-07-04 | The Biomembrane Institute | Extended type 1 chain glycosphingolipids as tumor-associated antigens |
DE4436164A1 (de) * | 1994-10-10 | 1996-04-11 | Hoechst Ag | Neue Kohlenhydratkonjugate als Inhibitoren der Zelladhäsion |
US6548643B1 (en) | 1994-11-16 | 2003-04-15 | Austin Research Institute | Antigen carbohydrate compounds and their use in immunotherapy |
US6841543B1 (en) | 1996-01-31 | 2005-01-11 | President And Fellows Of Harvard College | Methods of inhibiting production of T helper type 2 cytokines in human immune cells |
US6218363B1 (en) * | 1996-08-28 | 2001-04-17 | Thomas Jefferson University | MHC peptides and methods of use |
WO1998015286A1 (en) * | 1996-10-08 | 1998-04-16 | La Jolla Institute For Allergy & Immunology | Carbohydrate-specific cytolytic t cells |
US20070237785A1 (en) * | 1997-03-27 | 2007-10-11 | Institut Pasteur | Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof |
PT969873E (pt) * | 1997-03-27 | 2006-09-29 | Pasteur Institut | Hidrato de carbono glicopeptido antigene multiplo, vacina abrangendo o mesmo e seu uso |
US7550146B2 (en) * | 1997-04-16 | 2009-06-23 | Sloan-Kettering Institute For Cancer Research | Glycopeptide conjugates and uses thereof |
CA2286798C (en) | 1997-04-16 | 2014-01-07 | Sloan-Kettering Institute For Cancer Research | Alpha-o-linked glycoconjugates with clustered(2,6)-st epitopes, methods of preparation and uses thereof |
AUPO732997A0 (en) * | 1997-06-12 | 1997-07-03 | Csl Limited | Ganglioside immunostimulating complexes and uses thereof |
JP2002507577A (ja) * | 1998-03-25 | 2002-03-12 | スローン−ケッタリング インスティトュート フォア キャンサー リサーチ | 三量体抗原性o−結合複合糖ペプチド、その製造方法及びその使用 |
WO1999050392A1 (en) | 1998-03-31 | 1999-10-07 | Geron Corporation | Methods and compositions for eliciting an immune response to a telomerase antigen |
US7402307B2 (en) * | 1998-03-31 | 2008-07-22 | Geron Corporation | Method for identifying and killing cancer cells |
AU760669B2 (en) * | 1998-04-28 | 2003-05-22 | Galenica Pharmaceuticals, Inc. | Polysaccharide-antigen conjugates |
US20030091546A1 (en) * | 1998-11-12 | 2003-05-15 | Barber Jack R. | Methods of suppressing immune response by gene therapy |
EP1210355B1 (en) | 1999-08-20 | 2006-05-10 | Sloan-Kettering Institute For Cancer Research | Glycoconjugates, glycoamino, acids, intermediates thereto, and uses thereof |
US7854934B2 (en) * | 1999-08-20 | 2010-12-21 | Sloan-Kettering Institute For Cancer Research | Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
US7824687B2 (en) | 1999-08-20 | 2010-11-02 | Sloan-Kettering Institute For Cancer Research | Clustered multi-antigenic carbohydrate constructs, methods for their preparation, and uses thereof |
DE10005275A1 (de) * | 2000-02-07 | 2001-08-09 | Bayer Ag | Neuartige Glycokonjugate |
US20030049253A1 (en) * | 2001-08-08 | 2003-03-13 | Li Frank Q. | Polymeric conjugates for delivery of MHC-recognized epitopes via peptide vaccines |
UA79952C2 (en) * | 2001-12-10 | 2007-08-10 | Kabulesh Mafatlal Khamar | MYCOBACTERIUM w APPLICATIONS FOR CANCER TREATMENT |
US7318926B2 (en) * | 2003-02-06 | 2008-01-15 | Tripep Ab | Glycosylated specificity exchangers |
US20070134273A1 (en) * | 2004-02-10 | 2007-06-14 | Francois Romagne | Composition and method for the treatment of carcinoma |
EP1877447B1 (en) | 2005-05-05 | 2016-12-21 | Sensient Flavors Inc. | Production of beta-glucans and mannans |
JP2009525946A (ja) | 2005-12-20 | 2009-07-16 | デューク・ユニヴァーシティ | 増強された薬理学的性質を有する活性物質を送達するための方法および組成物 |
WO2010086294A2 (en) | 2009-01-28 | 2010-08-05 | Epimmune Inc. | Pan-dr binding polypeptides and uses thereof |
MX362513B (es) | 2010-03-23 | 2019-01-22 | Intrexon Corp | Vectores que expresan de manera condicional proteinas terapeuticas, celulas hospedadoras que comprenden vectores, y usos de los mismos. |
EP2500033A1 (en) | 2011-03-17 | 2012-09-19 | Institut Pasteur | Method for preparing muliple antigen glycopeptide carbohydrate conjugates |
JP2014524796A (ja) | 2011-06-28 | 2014-09-25 | イノビオ ファーマシューティカルズ,インコーポレイティド | 低侵襲表皮電気穿孔装置 |
EP2606897A1 (en) * | 2011-12-22 | 2013-06-26 | Laboratorios Del. Dr. Esteve, S.A. | Methods and compositions for the treatment of diseases caused by enveloped viruses |
US11433098B2 (en) | 2017-07-12 | 2022-09-06 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for treatment of cancers harboring an H3K27M mutation |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2004744B (en) * | 1977-09-28 | 1982-05-26 | Sanderson A R | Immonulogical preparations |
CA1335883C (en) * | 1986-07-08 | 1995-06-13 | Bryan Michael Longenecker | Enhancement of the cellular immune response |
JP2921574B2 (ja) * | 1988-02-01 | 1999-07-19 | アメリカン・サイアナミド・カンパニー | 接合体ワクチンの担体分子としてのt細胞のエピトープ |
WO1989007448A1 (en) * | 1988-02-12 | 1989-08-24 | Regents Of The University Of California | Use of synthetic peptides to generate and manipulate cellular immunity |
US5229289A (en) * | 1988-03-11 | 1993-07-20 | The Biomembrane Institute | Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human and with synthetic carbohydrate-carrier conjugates |
CA1337403C (en) * | 1988-03-28 | 1995-10-24 | Biomembrane Institute (The) | Methods for the production of antibodies and induction of immune responses to tumor-associated gangliosides by immunization with ganglioside lactones |
WO1991001146A1 (en) * | 1989-07-14 | 1991-02-07 | Praxis Biologics, Inc. | Cytokine and hormone carriers for conjugate vaccines |
WO1991003494A1 (en) * | 1989-08-28 | 1991-03-21 | Pierce Chemical Company | Cationized carriers for immunogen production |
GB8924438D0 (en) * | 1989-10-31 | 1989-12-20 | Hoffmann La Roche | Vaccine composition |
IT1237764B (it) * | 1989-11-10 | 1993-06-17 | Eniricerche Spa | Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici. |
-
1993
- 1993-04-22 IL IL10550393A patent/IL105503A/en not_active IP Right Cessation
- 1993-04-23 DE DE69329735T patent/DE69329735T2/de not_active Expired - Fee Related
- 1993-04-23 EP EP93912042A patent/EP0675733B1/en not_active Expired - Lifetime
- 1993-04-23 ES ES93912042T patent/ES2155070T3/es not_active Expired - Lifetime
- 1993-04-23 AT AT93912042T patent/ATE197903T1/de not_active IP Right Cessation
- 1993-04-23 DK DK93912042T patent/DK0675733T3/da active
- 1993-04-23 WO PCT/SE1993/000353 patent/WO1993021948A1/en active IP Right Grant
- 1993-04-23 AU AU42746/93A patent/AU676679B2/en not_active Ceased
- 1993-04-23 CA CA002134097A patent/CA2134097A1/en not_active Abandoned
- 1993-04-23 PT PT93912042T patent/PT675733E/pt unknown
- 1993-04-23 JP JP5519172A patent/JPH07506358A/ja not_active Abandoned
- 1993-04-27 MA MA23178A patent/MA22885A1/fr unknown
- 1993-04-27 IS IS4010A patent/IS4010A/is unknown
- 1993-04-27 US US08/054,860 patent/US5807559A/en not_active Expired - Fee Related
- 1993-04-28 MY MYPI93000788A patent/MY108864A/en unknown
- 1993-04-28 SI SI9300223A patent/SI9300223A/sl unknown
- 1993-04-28 TN TNTNSN93045A patent/TNSN93045A1/fr unknown
- 1993-04-28 CN CN93106340A patent/CN1096032A/zh active Pending
-
1995
- 1995-05-16 US US08/442,378 patent/US6033669A/en not_active Expired - Fee Related
-
2001
- 2001-03-05 GR GR20010400341T patent/GR3035501T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE69329735D1 (de) | 2001-01-11 |
EP0675733B1 (en) | 2000-12-06 |
DK0675733T3 (da) | 2001-05-07 |
EP0675733A1 (en) | 1995-10-11 |
AU4274693A (en) | 1993-11-29 |
IS4010A (is) | 1993-10-29 |
GR3035501T3 (en) | 2001-06-29 |
IL105503A (en) | 1999-05-09 |
CA2134097A1 (en) | 1993-11-11 |
CN1096032A (zh) | 1994-12-07 |
MY108864A (en) | 1996-11-30 |
MA22885A1 (fr) | 1993-12-31 |
DE69329735T2 (de) | 2001-08-02 |
ES2155070T3 (es) | 2001-05-01 |
WO1993021948A1 (en) | 1993-11-11 |
JPH07506358A (ja) | 1995-07-13 |
IL105503A0 (en) | 1993-08-18 |
PT675733E (pt) | 2001-05-31 |
AU676679B2 (en) | 1997-03-20 |
TNSN93045A1 (fr) | 1994-03-17 |
US6033669A (en) | 2000-03-07 |
ATE197903T1 (de) | 2000-12-15 |
US5807559A (en) | 1998-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SI9300223A (en) | Immunogenic peptides/carbohydrate conjugates and process for their production | |
Yin et al. | Recent development in carbohydrate based anticancer vaccines | |
US8357777B2 (en) | Enhanced immunogenicity of tumor associated antigens by addition of αgal epitopes | |
Abdel‐Aal et al. | Immune and anticancer responses elicited by fully synthetic aberrantly glycosylated MUC1 tripartite vaccines modified by a TLR2 or TLR9 agonist | |
Danishefsky et al. | From the laboratory to the clinic: a retrospective on fully synthetic carbohydrate‐based anticancer vaccines | |
Galli-Stampino et al. | T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity | |
Singhal et al. | Induction of α-N-acetylgalactosamine-O-serine/threonine (Tn) antigen-mediated cellular immune response for active immunotherapy in mice | |
Karmakar et al. | Synthesis of a liposomal MUC1 glycopeptide-based immunotherapeutic and evaluation of the effect of L-rhamnose targeting on cellular immune responses | |
Sarkar et al. | Synthesis and immunological evaluation of a MUC1 glycopeptide incorporated into l-rhamnose displaying liposomes | |
Becker et al. | Synthetic glycopeptides from the mucin family as potential tools in cancer immunotherapy | |
US20070275019A9 (en) | Vaccines directed to cancer-associated carbohydrate antigens | |
Reintjens et al. | Self-adjuvanting cancer vaccines from conjugation-ready lipid A analogues and synthetic long peptides | |
US20130149331A1 (en) | Rhamnose and forssman conjugated immunogenic agents | |
Warren et al. | Synthetic glycopeptide-based vaccines | |
Marqvorsen et al. | Going native: synthesis of glycoproteins and glycopeptides via native linkages to study glycan-specific roles in the immune system | |
US20160022826A1 (en) | Carbohydrate-modified glycoproteins and uses thereof | |
Franco | Glycoconjugates as vaccines for cancer immunotherapy: clinical trials and future directions | |
US20220233668A1 (en) | Glycopeptide vaccine | |
Liu et al. | Design, synthesis, and preliminary immunological studies of MUC1-based antitumor vaccines adjuvanted with R-and S-FSL-1 | |
Zhang et al. | Ganglioside GM3-based anticancer vaccines: Reviewing the mechanism and current strategies | |
KR20060125675A (ko) | 항원 전달 시스템 | |
EP1117432A1 (en) | Carbohydrate vaccines for viral diseases |